Taking into account the involvement of APP in synaptogenesis and the functioning of the nervous system, this approach to the treatment of AD seems unpromising, since a decrease in the expression of APP and related proteins can lead to undesirable side effects. The gene discussed is APP; the disease is Alzheimer disease.